Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
NCT00068913
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
35
Enrollment
NIH
Sponsor class
Conditions
MELAS Syndrome
Interventions
DRUG:
Dichloroacetate
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)